Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Body

Showing results (71-80 of 213) with videos related to

Pageof 22
Sort By:
Cancer Treatment Reviews|July 1, 1996
Use of bisphosphonates in cancer patientsJ J Body, R E Coleman, M Piccart
Current Opinion in Oncology|July 11, 2000
Opioid switch to oral methadone in cancer painI Mancini, D A Lossignol, J J Body
Bone and Mineral|December 1, 1991
Efficacy and safety of the bisphosphonate tiludronate for the treatment of tumor-associated hypercalcemiaJ C Dumon, A Magritte, J J Body
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
Effects of estrogens and calcium on calcitonin secretion in postmenopausal womenJ J Body, M Struelens, A Borkowski, et al.
International Journal of Cancer|June 4, 1998
Establishment and characterization of three new breast-cancer cell linesB Siwek, D Larsimont, M Lacroix, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1983
Serum immunoreactive calcitonin: useful as a general tumor marker?J J Body, G Kellermann, C Muquardt, et al.
Revue Medicale De Bruxelles|June 5, 2001
[Terminal medical interventions: psychosocial, medical, ethical and legal aspects]M Englert, A Ronson, D Lossignol, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 1, 1986
Serum osteocalcin (BGP) in tumor-associated hypercalcemiaJ J Body, A Cleeren, M Pot, et al.
Revue Medicale De Liege|March 15, 1988
[Bone metastases and hypercalcemia in cancer]J J Body, F Glibert, S Nejai, et al.
Melanoma Research|October 12, 2001
Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonatesJ M des Grottes, J C Dumon, J J Body
Pageof 22

Showing results (71-80 of 213) with videos related to

Sort By:
Pageof 22
Cancer Treatment Reviews|July 1, 1996
Use of bisphosphonates in cancer patientsJ J Body, R E Coleman, M Piccart
Current Opinion in Oncology|July 11, 2000
Opioid switch to oral methadone in cancer painI Mancini, D A Lossignol, J J Body
Bone and Mineral|December 1, 1991
Efficacy and safety of the bisphosphonate tiludronate for the treatment of tumor-associated hypercalcemiaJ C Dumon, A Magritte, J J Body
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
Effects of estrogens and calcium on calcitonin secretion in postmenopausal womenJ J Body, M Struelens, A Borkowski, et al.
International Journal of Cancer|June 4, 1998
Establishment and characterization of three new breast-cancer cell linesB Siwek, D Larsimont, M Lacroix, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 1, 1983
Serum immunoreactive calcitonin: useful as a general tumor marker?J J Body, G Kellermann, C Muquardt, et al.
Revue Medicale De Bruxelles|June 5, 2001
[Terminal medical interventions: psychosocial, medical, ethical and legal aspects]M Englert, A Ronson, D Lossignol, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 1, 1986
Serum osteocalcin (BGP) in tumor-associated hypercalcemiaJ J Body, A Cleeren, M Pot, et al.
Revue Medicale De Liege|March 15, 1988
[Bone metastases and hypercalcemia in cancer]J J Body, F Glibert, S Nejai, et al.
Melanoma Research|October 12, 2001
Hypercalcaemia of melanoma: incidence, pathogenesis and therapy with bisphosphonatesJ M des Grottes, J C Dumon, J J Body
Pageof 22